Lefèvre J P, Martínez F, Sørensen M. "Method for the Synthesis of N-(1-(2-Isonicotinoylhydrazinyl)-1-oxopropan-2-yl)adamantane-1-carboxamide" [P]. European Patent, EP 3866403 A1, 2016-10-05.
发明人王建平,罗永刚,钱学锋. "A Process for Preparing High-Purity N-(1-(2-Isonicotinoylhydrazinyl)-1-oxopropan-2-yl)adamantane-1-carboxamide" [P]. 中国发明专利, 专利号 CN 110299247 A, 授权公告日 2020-06-09.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2021, 2200, 6344-6359.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chromatographia, 2016, 650, (2), 4616-4630.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of N-(1-(2-Isonicotinoylhydrazinyl)-1-oxopropan-2-yl)adamantane-1-carboxamide Using HRMS and NMR". Anal. Chem., 2015, 1796, (10), 1880-1898.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Food Chem., 2013, 1291, 2686-2699.